The FDA is now advising manufacturers to develop the 2024-2025 COVID-19 vaccines using the KP.2 strain for the formula, the agency announced June 13.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA to vaccinemakers: Updated COVID shots should target KP.2 variant
